Shuainan Liu Selected Research

Shuainan Liu Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2015
6	Hyperglycemia 01/2022 - 01/2017
6	Inflammation (Inflammations) 11/2021 - 01/2020
6	Insulin Resistance 06/2021 - 06/2013
5	Glucose Intolerance 11/2021 - 09/2017
3	Obesity 01/2017 - 05/2015
2	Dyslipidemias (Dyslipidemia) 04/2021 - 01/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2020 - 12/2018
2	Hyperalgesia 12/2020 - 12/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2021
1	Weight Gain 11/2019
1	Necrosis 11/2019
1	Fatty Liver 01/2019
1	Carcinoma (Carcinomatosis) 05/2018
1	Communicable Diseases (Infectious Diseases) 03/2017
1	Metabolic Diseases (Metabolic Disease) 03/2017
1	Neoplasms (Cancer) 03/2017
1	Body Weight (Weight, Body) 01/2017
1	Diabetes Mellitus 10/2015
1	Insulinoma 10/2015
1	Non-alcoholic Fatty Liver Disease 05/2015
1	Cataract (Cataracts) 01/2015
1	Hyperinsulinism (Hyperinsulinemia) 10/2010

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2010
6	Insulin (Novolin)FDA Link 01/2022 - 06/2013
6	Blood Glucose (Blood Sugar)IBA 11/2021 - 01/2017
3	Streptozocin (Streptozotocin)FDA Link 04/2021 - 12/2018
2	BerberineIBA 11/2021 - 01/2020
2	diphenyldiselenideIBA 04/2021 - 12/2020
2	NAD (NADH)IBA 12/2020 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 08/2020 - 09/2017
2	Pioglitazone (Actos)FDA Link 11/2019 - 05/2015
2	Exenatide (Byetta)FDA Link 09/2017 - 01/2017
1	LipopolysaccharidesIBA 11/2021
1	stachyoseIBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 06/2021
1	Hexosaminidases (Hexosaminidase)IBA 04/2021
1	AlbuminsIBA 04/2021
1	NitrogenIBA 04/2021
1	CreatinineIBA 04/2021
1	Urea (Carbamide)FDA LinkGeneric 04/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	TabletsIBA 01/2021
1	AlkaloidsIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2020
1	RGFP966IBA 11/2020
1	PowdersIBA 08/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020
1	Mucin-2IBA 08/2020
1	Volatile Fatty AcidsIBA 01/2020
1	GlucosidasesIBA 05/2019
1	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 05/2019
1	Acarbose FDA LinkGeneric 05/2019
1	DisaccharidasesIBA 05/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2019
1	Amylases FDA Link 05/2019
1	alpha-Glucosidases (Acid Maltase)IBA 05/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	GlucocorticoidsIBA 01/2019
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 12/2018
1	Flavoring AgentsIBA 12/2018
1	maltolIBA 12/2018
1	GlucokinaseIBA 05/2018
1	Glucagon (Glukagon)FDA Link 01/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 09/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 07/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017
1	LinagliptinIBA 01/2017
1	Galectin 3 (LGALS3)IBA 11/2016
1	6- (5- (3- fluorobenzyloxy)- 2- propoxybenzamido)nicotinic acidIBA 10/2015
1	LigandsIBA 05/2015
1	Pharmaceutical PreparationsIBA 05/2015
1	PPAR gammaIBA 05/2015
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2015
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2015
1	GalactitolIBA 01/2015
1	SolutionsIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	SugarsIBA 01/2015
1	Capsules (Microcapsules)IBA 01/2015
1	BPI 3006IBA 10/2010

Therapy/Procedure

3	Therapeutics 08/2020 - 01/2018
2	Injections 09/2017 - 01/2017
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Glycemic Control 01/2020
1	Subcutaneous Injections 09/2017
1	Slit Lamp 01/2015